Equity Profile

SOLV

Solventum Corporation

Health CareHealth Care Supplies$13.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Solventum Corporation operates in the health care sector, focusing on health care supplies. With a market cap of $13 billion, the company plays a crucial role in providing essential products that support patient care and medical facilities.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1-2026, Solventum reported an EPS of $1.48, exceeding expectations by 9.39%. The stock reacted positively, gaining 2.37% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given Solventum's strong track record of beating EPS estimates.

Bull Case

If Solventum continues its trend of positive surprises, it could signal robust demand for its products and further stock price appreciation.

Bear Case

Conversely, any signs of slowing revenue growth or increased costs could raise concerns about the company's future profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Solventum's history of beating EPS estimates, this figure will be critical in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Investors will closely watch for any shifts in revenue growth as it could indicate changes in market demand or competitive pressures.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to capitalize on emerging health care trends, particularly in telehealth and home care solutions.

Supporting Evidence

Historical EPS surprises indicate strong operational performance that may not be fully reflected in current estimates.

Options pricing suggests a higher expected move than what has been typical, indicating potential for a significant reaction.

The lack of recent peer reports may mean that Solventum's unique position in the market is not being fully appreciated.

Key Risk

If revenue growth shows unexpected strength, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Solventum can maintain its growth trajectory amid increasing competition and market pressures.

Bull Confirmed If

A Q2-2026 EPS of $1.50 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $1.35 would suggest potential issues with profitability and could confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by around 1.14%, confirming strong demand and positive market sentiment.

In-Line / Cautious

If results are in line but management expresses caution, the stock may experience minimal movement as investors reassess future growth prospects.

Miss

A miss could lead to a decline, with historical patterns suggesting a potential drop in stock price, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in health care supplies.
2Management's commentary on market demand trends and competitive landscape.
3Insights into cost management strategies and their impact on margins.
4Updates on supply chain stability and any potential disruptions.
5Future guidance on expected revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1-2026, Solventum reported an EPS of $1.48, exceeding expectations by 9.39%. The stock reacted positively, gaining 2.37% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given Solventum's strong track record of beating EPS estimates.

Bull Case

If Solventum continues its trend of positive surprises, it could signal robust demand for its products and further stock price appreciation.

Bear Case

Conversely, any signs of slowing revenue growth or increased costs could raise concerns about the company's future profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Solventum's history of beating EPS estimates, this figure will be critical in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Investors will closely watch for any shifts in revenue growth as it could indicate changes in market demand or competitive pressures.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to capitalize on emerging health care trends, particularly in telehealth and home care solutions.

Supporting Evidence

Historical EPS surprises indicate strong operational performance that may not be fully reflected in current estimates.

Options pricing suggests a higher expected move than what has been typical, indicating potential for a significant reaction.

The lack of recent peer reports may mean that Solventum's unique position in the market is not being fully appreciated.

Key Risk

If revenue growth shows unexpected strength, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Solventum can maintain its growth trajectory amid increasing competition and market pressures.

Bull Confirmed If

A Q2-2026 EPS of $1.50 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $1.35 would suggest potential issues with profitability and could confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by around 1.14%, confirming strong demand and positive market sentiment.

In-Line / Cautious

If results are in line but management expresses caution, the stock may experience minimal movement as investors reassess future growth prospects.

Miss

A miss could lead to a decline, with historical patterns suggesting a potential drop in stock price, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in health care supplies.
2Management's commentary on market demand trends and competitive landscape.
3Insights into cost management strategies and their impact on margins.
4Updates on supply chain stability and any potential disruptions.
5Future guidance on expected revenue growth and market expansion plans.